Carregant...
AICAR TREATMENT REDUCES INTERSTITIAL FIBROSIS IN AGING MICE Suppression of the Inflammatory Fibroblast
In 2030, elderly people will represent 20% of the United States population. Even now, chronic cardiac diseases, especially heart failure with preserved systolic function (HFpEF), are the most expensive DRGs for Medicare. Progressive interstitial fibrosis in the aging heart is well recognized as an i...
Guardat en:
| Publicat a: | J Mol Cell Cardiol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600709/ https://ncbi.nlm.nih.gov/pubmed/28826664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.08.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|